The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.
John R. Corboy, MD
Advertisement
Articles by John R. Corboy, MD
Advertisement
Latest Updated Articles
Medication Discontinuation in Patients With Multiple Sclerosis: A Conversation With John R. Corboy, MDPublished: June 21st 2017 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Showcasing Sustained Benefits in Myasthenia Gravis Research at AANEM 2025: Kimberly Moran, PhD, MBA
2
Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C
3
NeurologyLive® Brain Games: November 2, 2025
4
This Week on NeurologyLive® — November 3, 2025
5
